Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial.
Cao M, Lu H, Yan S, Pang H, Sun L, Li C, Chen X, Liu W, Hu J, Huang J, Xing Y, Zhang N, Chen Y, He T, Zhao D, Sun Y, Zhao L, Liu X, Cai L.
Cao M, et al. Among authors: zhao d, zhao l.
BMC Cancer. 2023 May 19;23(1):463. doi: 10.1186/s12885-023-10768-8.
BMC Cancer. 2023.
PMID: 37208633
Free PMC article.
Clinical Trial.